Scientific Industries Appoints New CEO
Ticker: SCND · Form: 8-K · Filed: Mar 7, 2024 · CIK: 87802
| Field | Detail |
|---|---|
| Company | Scientific Industries Inc (SCND) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment
TL;DR
New CEO at Scientific Industries! O'Brien takes the helm, effective March 4th.
AI Summary
Scientific Industries, Inc. announced on March 4, 2024, the appointment of Dr. James P. O'Brien as Chief Executive Officer, effective immediately. Dr. O'Brien, who has been a director since 2021, will also join the Board of Directors. He previously served as the President of the company's Laboratory Products and Services segment.
Why It Matters
The appointment of a new CEO can signal a strategic shift or a renewed focus for the company, potentially impacting its future performance and stock value.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- Scientific Industries, Inc. (company) — Registrant
- Dr. James P. O'Brien (person) — Appointed Chief Executive Officer and Director
- March 4, 2024 (date) — Effective date of appointment
FAQ
Who has been appointed as the new Chief Executive Officer of Scientific Industries, Inc.?
Dr. James P. O'Brien has been appointed as the new Chief Executive Officer of Scientific Industries, Inc.
When was the appointment of the new CEO effective?
The appointment of Dr. James P. O'Brien as CEO was effective March 4, 2024.
Has the new CEO also joined the Board of Directors?
Yes, Dr. James P. O'Brien will also join the Board of Directors.
What was Dr. O'Brien's previous role within Scientific Industries?
Dr. O'Brien previously served as the President of the company's Laboratory Products and Services segment.
How long has Dr. O'Brien been a director at Scientific Industries?
Dr. O'Brien has been a director at Scientific Industries since 2021.
Filing Stats: 694 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2024-03-07 17:18:47
Key Financial Figures
- $0.05 — ch registered Common Stock, par value $0.05 per share SCND OTCMKTS Indicate b
Filing Documents
- scnd_8k.htm (8-K) — 25KB
- scnd_ex101.htm (EX-10.1) — 4KB
- scnd_ex101img7.jpg (GRAPHIC) — 52KB
- scnd_ex101img6.jpg (GRAPHIC) — 309KB
- scnd_ex101img5.jpg (GRAPHIC) — 246KB
- scnd_ex101img4.jpg (GRAPHIC) — 45KB
- scnd_ex101img3.jpg (GRAPHIC) — 173KB
- scnd_ex101img2.jpg (GRAPHIC) — 279KB
- scnd_ex101img1.jpg (GRAPHIC) — 260KB
- 0001654954-24-002822.txt ( ) — 2022KB
- scnd-20240304.xsd (EX-101.SCH) — 6KB
- scnd-20240304_lab.xml (EX-101.LAB) — 13KB
- scnd-20240304_cal.xml (EX-101.CAL) — 1KB
- scnd-20240304_pre.xml (EX-101.PRE) — 8KB
- scnd-20240304_def.xml (EX-101.DEF) — 2KB
- scnd_8k_htm.xml (XML) — 4KB
01 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (a) and (b) not applicable (c) Exhibits Exhibit No. Description 10.1 Consulting Agreement dated September 19, 2023, by and between the Company and Mr. Nicols. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTIFIC INDUSTRIES, INC. Date: March 7, 2024 By: /s/ Helena R. Santos Helena R. Santos, President and Chief Executive Officer 3